1 Revising FDAs Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests FDA/Industry Statistics Workshop September 28-29, 2006.
Fast track drugs- Rapid study and Approval
Fast track drugs - Rapid study and Approval
Dr. ajmal nasir
FDA’s Regulation of Products Derived Through Nanotechnology: Controversies and Potential Impacts on Nanomedicine Ricardo Carvajal Hyman, Phelps & McNamara,
Ethical Issues in Phase I Oncology Trials
Preventive Controls Phase 2 Workgroup 1.
